UPB (Upstream Pharma) Market Capitalization
Upstream Bio Inc (UPB) is developing targeted therapy for severe asthma, supported by substantial capital that shields the business from market volatility. The development of unique antibodies could grant the company pricing power upon successful trial results. This daily price chart reflects a value of 0.18. Cost efficiency is achieved by outsourcing clinical trials to a network of external contractors, eliminating dependence on individual laboratories.
Metric breakdowns and analytics for Upstream Pharma (UPB)
- market price and analyst price targets:
- business market valuation indicators:
- issuer book value statistics:
- business debt structure and liquidity details:
Total Debt to Capital Upstream Bio Inc|UPB - Long-Term Debt to Capital|Short-Term Debt to Equity Upstream Bio Inc|UPB - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Upstream Pharma|UPB - Company Long-Term Liabilities|Company Short-Term Debts Upstream Bio|Quick Liquidity Indicator upstreambio.com
- business earnings and investment ratios data:
UPB - Final Profit|Projected Future Earnings Upstream Bio Inc|UPB - Business Payback Period|Future Price to Earnings Upstream Bio Corp|UPB - Price/Earnings to Growth Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Upstream Pharma|UPB - Operating profit before deduction of amortization|Net earnings per share for the last 12 months Upstream Bio|UPB - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months upstreambio.com|UPB - Earnings per share growth this year|Earnings growth forecast for next year Upstream Bio Inc
Summary company analysis:UPB (Upstream Bio)
Market capitalization reflects the aggregate value of all the issuer's shares, serving as a tool for the continuous discounting of future cash flows by investors. Analyzing the market's aggregate valuation of Upstream Bio Inc (UPB) allows for tracking the impact of binary risks, where the metric's volatility correlates directly with the development success of the sole key antibody amid a high concentration of the product portfolio.
Competitors of Upstream Bio Inc (UPB)
Market Value argenx ARGX|BNTX (BioNTech Inc.) - Market Valuation|Abivax S.A. - Market Capitalization|ADMA: Market Value|Protagonist Therapeutics (PTGX) - Market Value|Market Valuation IMVT (immunovant.com)|KNSA (Kiniksa) - Market Capitalization|GRFS: Market Value|Market Capitalization ADPT|Market Capitalization Celldex Corp (CLDX)|Market Value Aurinia Pharmaceuticals AUPH|Market Value BCRX|VERA - Market Value|Dianthus Therapeutics Inc (DNTH) - Market Valuation|PHVS: Market Capitalization|AbCellera Biologics Inc. (ABCL) - Market Capitalization|Market Valuation TRML|PGEN: Market Value|Market Capitalization PHAR|Market Capitalization Nektar Therapeutics Inc|Market Value Zenas Biopharma, Inc. ZBIO|IMNM - Market Valuation|GOSS - Market Value|kalvista.com (KALV) - Market Valuation|SEPN (Septerna) - Market Valuation|Pieris Pharma (PVLA) - Market Capitalization|Market Value Savara Corp|Market Capitalization RIGL (Rigel Corp)|Market Capitalization ANAB|ATXS - Market Value|enGene - Market Valuation|Market Capitalization rapt.com RAPT|JBIO - Market Value|Market Valuation ACRS|Kyverna Therapeutics (KYTX) - Market Value|TLSA - Market Capitalization|Market Valuation CABA|VTYX (Ventyx Biosciences Inc.) - Market Value|Market Value Theratechnologies Inc (THTX)|AVTX (Avalo Therapeutics Inc) - Market Value|Market Capitalization ELDN (Eledon Pharmaceuticals)|agenusbio.com (AGEN) - Market Value|Climb Bio - Market Capitalization|ZURA - Market Capitalization|aTyr (ATYR) - Market Value|Market Valuation Adagene Inc.|Market Valuation IMA|STTK: Market Value|Market Capitalization EQ|Market Value CNTB (connectbiopharm.com)|Market Capitalization IMUX (Immunic)|Market Capitalization Atara Biotherapeutics, Inc. (ATRA)|IFRX - Market Value|Market Value x4pharma.com|ACET (adicetbio.com) - Market Valuation|Celularity - Market Value|INMB (INmune Bio Corp) - Market Capitalization|Barinthus Biotherapeutics Corp (BRNS) - Market Capitalization|Market Value Kezar Life Sciences (KZR)|sabbiotherapeutics.com - Market Capitalization|Market Capitalization AKTX (Akari Therapeutics Plc)|ENLV - Market Valuation|QTTB: Market Valuation|GOVX - Market Capitalization|Edesa Biotech, Inc. (EDSA) - Market Value|Market Valuation IBIO (ibioinc.com)|CARM (Carisma Therapeutics Inc) - Market Capitalization|Market Value XTLB|Market Value Bolt Biotherapeutics (BOLT)|HCWB: Market Valuation|Market Capitalization APVO (Aptevo Therapeutics Inc.)|Market Value AIM|Aditxt Corp - Market Capitalization|GRI - Market Capitalization|XORTX (XRTX) - Market Value|Vyome Therapeutics - Market Value|Market Value Revelation Biosciences|Market Valuation indaptusrx.com (INDP)|Market Capitalization SCNI|Market Capitalization calcimedica.com (CALI)|Affimed N.V. - Market Valuation|Market Value ALLK|HOOKIPA - Market Capitalization|Market Capitalization IGM Biosciences, Inc. IGMS|iTeos Therapeutics, Inc. (ITOS) - Market Value|Market Valuation Ocean Biomedical Inc|Market Value TC BioPharm (Holdings) PLC|Market Valuation Third Harmonic Bio Inc (THRD)
